SMOX was also found to be highly expressed in NSCLC tissues, and survival curves revealed that patients with lower levels of SMOX had a higher survival rate, suggesting its potential as a predictive target for NSCLC 33. Here, SMOX is linked to non-small cell lung carcinoma.